TuHURA Biosciences, Inc.

NASDAQ:HURA

Biotechnology

Healthcare
$1.37 +6.37%

+$0.14 today

Market cap
$87.31M
Beta
0.01
P/E (TTM)
-4.6
EPS (TTM)
-$0.52
52W Low $0.41High $3.90

Volume 0.19M

Average 0.85M

HURA Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

No reported Gross Margin figures are available to summarize.

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How HURA compares with its peers on the latest reported figures

HURA Competitors Peer median
Gross Margin for HURA and competitors
Company Period LTM level YoY 3-year change
INOInovio Pharmaceuticals, Inc.FY2025100.0% +0.0 pp+0.0 pp
SPROSpero Therapeutics, Inc.LTM Mar 2026100.0% +296.0 pp+0.0 pp
AGENAgenus Inc.LTM Mar 202652.1% +86.4 pp+130.9 pp
IRDOpus Genetics, Inc.LTM Mar 202649.6% +6.6 pp+0.0 pp
SEERSeer, Inc.LTM Mar 202648.3% +18.6 pp+9.2 pp
MCRBSeres Therapeutics, Inc.LTM Mar 2026-20.9% ——
HURATuHURA Biosciences, Inc.FY2025— ——
CGTXCognition Therapeutics, Inc.FY2025— ——
ABOSAcumen Pharmaceuticals, Inc.FY2025— ——
Peer median (excluding HURA) 50.9%+18.6 pp+0.0 pp

Competitors are the stored peer set for HURA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue60K60K55K00
Gross Profit(60K)(60K)(55K)00
Gross Margin—————
Research & Development15.17M9.31M2.66M13.34M20.53M
Selling, General & Admin7.45M5.43M5.73M3.87M7.58M
Operating Expenses22.62M14.74M8.4M17.65M31.8M
Depreciation & Amortization60K60K55K116.71K71.27K
EBITDA(21.97M)(14.59M)(8.27M)(17.43M)(29.36M)
EBITDA Margin—————
Operating Income(22.68M)(14.8M)(8.45M)(17.65M)(31.8M)
Operating Margin—————
Interest Income057.35K89.67K361.63K136.23K
Interest Expense629.29K018.69K4.14M625.28K
Other Income / Expenses21K147K131K(4.03M)1.74M
Income Before Tax(22.66M)(14.65M)(8.32M)(21.68M)(30.06M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(22.66M)(14.65M)(8.32M)(21.68M)(30.06M)
Net Margin—————
EPS (Basic)(903.04)(324.48)(11.29)(1.21)(0.63)
EPS (Diluted)(903.04)(324.48)(11.29)(1.21)(0.63)
Weighted Avg Shares27.83K46.29K752.91K18.66M47.93M
Weighted Avg Shares (Diluted)27.83K46.29K752.91K18.66M47.93M

TuHURA Biosciences, Inc.

NASDAQ:HURA

Intrinsic Alpha fair value

Locked

Current Price

$1.37

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.